HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	129.45B
Revenue (ttm)	119.52B
Net Income (ttm)	5.70B
Shares Out	30.00M
EPS (ttm)	190.10
PE Ratio	10.52
Forward PE	7.61
Dividend	35.00 (0.81%)
Ex-Dividend Date	Dec 27, 2024

Volume	52,066
Average Volume	67,445
Open	4,410.00
Previous Close	4,400.00
Day's Range	4,360.00 - 4,410.00
52-Week Range	3,865.00 - 12,630.00
Beta	0.56
RSI	31.71
Earnings Date	Mar 12, 2025

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd. engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supply of active ...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 320
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.